Zymeworks inc. (ZYME)

CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Cash flows from operating activities:
Net loss

-162,932

-145,437

-63,920

-52,196

-28,993

-36,556

-13,096

-10,590

-15,684

-10,406

0

0

0

Items not involving cash:
Depreciation and amortization of property and equipment

2,591

2,312

2,053

1,961

1,933

1,880

1,868

1,836

1,806

1,681

0

0

0

Amortization of intangible assets

3,440

3,113

2,812

2,494

2,127

1,750

1,371

1,105

1,064

1,058

0

0

0

Impairment on acquired IPR&D

-

-

-

-

-

-

-

-

-

1,536

0

0

0

Stock-based compensation (recovery) expense

41,902

48,996

22,463

18,987

14,276

13,441

12,401

10,387

3,996

3,429

0

0

0

Amortization and impairment of operating lease right-of-use assets

0

-

-

-

0

-

-

-

-

-

-

-

-

Deferred income tax expense

375

726

14

13

39

17

0

0

0

-

-

-

-

Non-cash consideration from licensing agreement

0

-

-

-

0

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration

249

271

0

0

0

-

-

-

-

-

-

-

-

Change in fair value of warrant liabilities (note 10)

-

-

-

-

-

3,565

3,435

3,248

-553

-2,450

0

0

0

Accretion on long-term debt

-

-

-

-

-

-

-

-

-

248

0

0

0

Unrealized foreign exchange (gain) loss

3,984

-504

150

-65

-323

48

-181

-23

20

254

0

0

0

Changes in non-cash operating working capital:
Accounts receivable

7,950

1,828

3,071

2,407

653

119

73

-1,128

-419

-2,409

0

0

0

SR&ED receivables

-

-

-

-

-

-

0

0

-88

-

0

0

0

Prepaid expenses and other current assets

-1,582

8,680

5,538

5,878

7,738

251

-740

-870

-701

202

0

0

0

Accounts payable and accrued liabilities

25,005

21,572

15,115

4,394

3,461

3,684

4,761

5,373

-248

-358

0

0

0

Operating lease liabilities

-263

-795

0

0

0

-

-

-

-

-

-

-

-

Deferred revenue

0

-3,530

0

0

0

-

-

-

-

-

-

-

-

Income taxes payable

-492

-299

-114

54

442

140

0

0

0

-

-

-

-

Net cash used in operating activities

-98,038

-81,853

4,606

2,669

20,446

24,177

13,087

13,752

-4,655

219

0

0

0

Cash flows from financing activities:
Proceeds from public offering, net of issuance costs (note 8a)

0

-

0

0

0

-

-

-

-

-

-

-

-

Issuance of common shares on exercise of options (note 8e)

6,583

5,498

2,788

1,369

1,010

682

1,021

1,020

549

965

0

0

0

Issuance of common shares through employee stock purchase plan

784

598

579

366

366

233

0

0

0

-

-

-

-

Deferred financing fees

0

-

-

-

0

-

-

-

-

-

-

-

0

Finance lease payments

12

16

16

17

16

11

10

10

10

9

0

0

0

Net cash provided by financing activities

495,924

193,661

191,357

189,453

91,869

91,431

91,702

92,445

50,097

49,951

0

0

0

Cash flows from investing activities:
Net (purchases) redemptions of short-term and long-term investments

0

-

-

-

0

-

-

-

-

-

-

-

-

Purchase of short-term investments

-

-

-

-

-

105,626

85,001

74,412

7,562

27,767

0

0

0

Acquisition of property and equipment

6,821

6,322

4,440

1,758

725

803

926

1,053

1,211

2,015

0

0

0

Acquisition of intangible assets

0

-

-

-

2,561

2,617

2,631

1,182

1,159

1,106

0

0

0

Net cash (used in) provided by investing activities

-252,368

-25,592

26,591

36,062

-99,576

-109,046

-88,558

-76,647

-24,942

-30,888

0

0

0

Effect of exchange rate changes on cash and cash equivalents

793

30

-85

-43

-546

-303

-188

-172

35

227

0

0

0

Net change in cash and cash equivalents

146,311

86,246

222,469

228,141

12,193

6,259

16,043

29,378

20,535

19,509

0

0

0

Supplemental disclosure of non-cash investing and financing items:
Leased assets obtained in exchange for operating lease liabilities

996

7,026

0

0

0

-

-

-

-

-

-

-

-

Deferred financing fees in accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

0

Acquisition of property and equipment in accounts payable and accrued liabilities

935

607

1,375

1,933

520

382

-223

107

-197

123

0

0

0